BIO-TECHNE Corp cotiza a 72.48 USD y tiene una capitalización bursátil de $11.4B. En los últimos 12 meses ha facturado $1.2B con un margen de flujo de caja libre del 21.7%. Cotiza a 43.2 veces su flujo de caja libre (P/FCF) y a un PER de 62.5. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences seg…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.52 | $0.53 | $0.46 |
| Estimado | $0.45 | $0.52 | $0.53 | $0.43 |
| Sorpresa | — | +0.0% | +0.0% | +7.0% |
| Métrica | TECH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 65.8% | 57.0% | +8.7% |
| Operating Margin | 20.7% | -38.6% | +59.3% |
| Net Margin | 15.0% | -33.6% | +48.5% |
| FCF Margin | 21.7% | -13.9% | +35.5% |
| ROE | 8.6% | -40.4% | +49.0% |
| ROA | 7.0% | -32.0% | +39.0% |
| Current Ratio | 4.55 | 2.84 | +1.71 |
| Debt / Equity | 0.09 | 0.28 | -0.19 |